Suchergebnisse - "Van Dromme, Ilse"

PubPharm (20)

1

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features

enthalten in: Nature communications | 2024

von Magaret, C. | Li, L. | deCamp, A. | +47

UpdateOf: Res Sq. 2023 May 31;:. - PMID 37398105

2

Genotypic and phenotypic characterization of influenza A viral variants in study participants treated with pimodivir in the phase 2b TOPAZ study

enthalten in: Antiviral therapy | 2023

von Vingerhoets, J. | Van Dromme, I. | van Duijnhoven, W. | +3

3

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features

enthalten in: Research square | 2023

von Magaret, C. | Li, L. | deCamp, A. | +40

UpdateIn: Nat Commun. 2024 Mar 11;15(1):2175. - PMID 38467646

4

Psychometric evaluation of the Symptoms of Infection with Coronavirus-19 (SIC) : results from a cross-sectional study and a phase 3 clinical trial

enthalten in: Journal of patient-reported outcomes | 2023

von Chan, E. | Williams, V. | Romano, C. | +13

5

Psychometric evaluation of the Symptoms of Infection with Coronavirus-19 (SIC): results from a cross-sectional study and a phase 3 clinical trial

enthalten in: Journal of patient-reported outcomes | 2023

von Chan, E. | Williams, V. | Romano, C. | +13

6

The Hospital Recovery Scale : A clinically useful endpoint in patients hospitalized with influenza

enthalten in: Contemporary clinical trials | 2022

von van Duijnhoven, W. | Van Dromme, I. | Haesendonckx, S. | +2

7

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2) : results of a randomised, double-blind, placebo-controlled, phase 3 trial

enthalten in: The Lancet. Infectious diseases | 2022

von Hardt, K. | Vandebosch, A. | Sadoff, J. | +115

CommentIn: Lancet Infect Dis. 2022 Dec;22(12):1654-1655. - PMID 36113536

8

A Phase 2 Study of Pimodivir (JNJ-63623872) in Combination With Oseltamivir in Elderly and Nonelderly Adults Hospitalized With Influenza A Infection : OPAL Study

enthalten in: The Journal of infectious diseases | 2022

von O'Neil, B. | Ison, M. | Hallouin-Bernard, M. | +11

9

Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S

enthalten in: The New England journal of medicine | 2022

von Sadoff, J. | Gray, G. | Vandebosch, A. | +127

10

Efficacy and Safety of a Booster Regimen of Ad26.COV2.S Vaccine against Covid-19

enthalten in: bioRxiv.org | 2022

von Hardt, K. | Vandebosch, A. | Sadoff, J. | +14